-transparent.png){kind=logo}
E-cadherin (E-CD) expression and its clinicopathological implication were investigated in 26 patients with breast cancer by immunohistochemical staining. 12 out of 26 primary lesions (46%) express strong and homogeneous expression of E-cadherin (preserved type), while in 14 cases (54%), degree of E-CD expression was reduced, i.e., 8 patients with heterogeneous staining, 2 cases with weak but homogeneous, and 4 cases with lost expression of E-CD (reduced type). However, there was no statistically significant correlation among decrease of E-CD expression, histological features, and advanced stages of breast cancer. Analysis on survivals showed better prognosis in the group with preserved E-CD expression than without E-CD (follow up was more than 96 months or until death). These findings suggests that the patients with decreased E-CD expression may be associated with metastasis resulting in poor prognosis, and E-CD expression could be one of the prognostic factors.
R Hirayama, and
Z Nihei, and
T Osanai, and
W Ichikawa, and
K Yoshinaga, and
S Sawai, and
Y Mishima
October 1994,
The Journal of pathology,
R Hirayama, and
Z Nihei, and
T Osanai, and
W Ichikawa, and
K Yoshinaga, and
S Sawai, and
Y Mishima
January 1997,
Oncology reports,
R Hirayama, and
Z Nihei, and
T Osanai, and
W Ichikawa, and
K Yoshinaga, and
S Sawai, and
Y Mishima
January 2007,
International journal of health sciences,
R Hirayama, and
Z Nihei, and
T Osanai, and
W Ichikawa, and
K Yoshinaga, and
S Sawai, and
Y Mishima
December 2001,
British journal of cancer,
R Hirayama, and
Z Nihei, and
T Osanai, and
W Ichikawa, and
K Yoshinaga, and
S Sawai, and
Y Mishima
January 1995,
Neoplasma,
R Hirayama, and
Z Nihei, and
T Osanai, and
W Ichikawa, and
K Yoshinaga, and
S Sawai, and
Y Mishima
January 2008,
Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie,
R Hirayama, and
Z Nihei, and
T Osanai, and
W Ichikawa, and
K Yoshinaga, and
S Sawai, and
Y Mishima
March 2017,
Oncotarget,
R Hirayama, and
Z Nihei, and
T Osanai, and
W Ichikawa, and
K Yoshinaga, and
S Sawai, and
Y Mishima
July 2016,
Acta oto-laryngologica,
R Hirayama, and
Z Nihei, and
T Osanai, and
W Ichikawa, and
K Yoshinaga, and
S Sawai, and
Y Mishima
January 1997,
Oncology reports,
R Hirayama, and
Z Nihei, and
T Osanai, and
W Ichikawa, and
K Yoshinaga, and
S Sawai, and
Y Mishima
May 2001,
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
